Drug Shortage and Ethical Issues: Integrating Multidisciplinary Perspectives with a Shared Ethical Framework

Area of Science:

• Medical Ethics
• Health Economics
• Pharmaceutical Policy

Background:

• Drug shortages present significant ethical dilemmas due to a lack of systematic and equitable resource allocation strategies.
• The COVID-19 pandemic highlighted the need for ethical frameworks to guide the allocation of scarce medical resources to patients.
• Factors such as limited manufacturing, regulatory hurdles, and rising costs contribute to the persistent challenge of drug shortages across medical subspecialties.

Purpose of the Study:

• To propose a combined ethical and economic framework for the systematic and equitable allocation of drugs during shortages.
• To address the ambiguity and ethical challenges faced by decision-makers when managing limited drug supplies.
• To provide a practical approach for healthcare providers and policymakers to navigate drug scarcity.

Main Methods:

• Review of existing ethical frameworks for resource allocation in healthcare.
• Examination of relevant economic principles and cost-benefit analyses.
• Integration of ethical considerations with economic factors to develop a comprehensive decision-making model.

Main Results:

• A combined ethical and economic framework can provide a structured process for drug allocation.
• Such a framework may reduce ethical ambiguity and promote equitable patient care during drug shortages.
• Proactive development of combined frameworks can improve the management of unpredictable drug supply issues.

Conclusions:

• Integrating ethical and economic perspectives is crucial for managing drug shortages effectively.
• A systematic, combined framework can enhance equitable drug distribution and patient care.
• Further development and implementation of such frameworks are needed to mitigate the impact of drug scarcity on healthcare systems.